Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
3026
DELISTED
Unilever NV New York Registry Shares
UN
| $1.37M | ﹤0.01% |
25,688
-13,638
| -35% | -$693K |
|
3027
Orion Energy Systems
OESX
$41.9M
| $1.36M | ﹤0.01% |
39,458
+17,748
| +82% | +$726K |
|
3028
iShares Core S&P 500 ETF
IVV
$882B
| – | – |
0
| – | – |
|
|
ARA
3029
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.35M | ﹤0.01% |
207,594
-22,668
| -10% | -$146K |
|
|
CIZN
3030
DELISTED
Citizens Holding Co.
CIZN
| $1.35M | ﹤0.01% |
54,076
+34,667
| +179% | +$777K |
|
|
PFSW
3031
DELISTED
PFSweb, Inc.
PFSW
| $1.35M | ﹤0.01% |
202,467
+91,674
| +83% | +$486K |
|
3032
Saga Communications
SGA
$58.1M
| $1.35M | ﹤0.01% |
52,619
+1,292
| +3% | +$34K |
|
3033
EVI Industries
EVI
$184M
| $1.34M | ﹤0.01% |
61,951
-1,701
| -3% | -$33.5K |
|
3034
Intrepid Potash
IPI
$449M
| $1.34M | ﹤0.01% |
135,795
-126
| -0.1% | -$1.31K |
|
3035
BHP
BHP
$211B
| $1.34M | ﹤0.01% |
30,273
+11,220
| +59% | +$439K |
|
|
VNET
3036
VNET Group
VNET
$2.02B
| $1.34M | ﹤0.01% |
56,186
| – | – |
|
|
NBSE
3037
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1.34M | ﹤0.01% |
7,624
+6,814
| +841% | +$1.14M |
|
3038
Choiceone Financial
COFS
$513M
| $1.33M | ﹤0.01% |
+45,167
| New | +$1.28M |
|
|
GFN
3039
DELISTED
General Finance Corporation
GFN
| $1.33M | ﹤0.01% |
198,482
+6,589
| +3% | +$40K |
|
|
CGC
3040
Canopy Growth
CGC
$401M
| $1.33M | ﹤0.01% |
8,423
+1,826
| +28% | +$296K |
|
|
MRLN
3041
DELISTED
Marlin Business Services Corp
MRLN
| $1.33M | ﹤0.01% |
157,203
-1,833
| -1% | -$14.2K |
|
3042
Duluth Holdings
DLTH
$158M
| $1.32M | ﹤0.01% |
179,417
-5,783
| -3% | -$29.5K |
|
3043
Eagle Bancorp Montana
EBMT
$187M
| $1.32M | ﹤0.01% |
75,989
+41,178
| +118% | +$702K |
|
|
NVMI
3044
Nova
NVMI
$12.3B
| $1.32M | ﹤0.01% |
27,364
+594
| +2% | +$25.2K |
|
|
MMAC
3045
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $1.31M | ﹤0.01% |
56,892
+2,040
| +4% | +$50.7K |
|
3046
Aquestive Therapeutics
AQST
$476M
| $1.31M | ﹤0.01% |
270,446
+121,357
| +81% | +$559K |
|
3047
Eastern Company
EML
$146M
| $1.3M | ﹤0.01% |
72,902
+2,327
| +3% | +$42.6K |
|
|
AGFS
3048
DELISTED
AgroFresh Solutions Inc
AGFS
| $1.3M | ﹤0.01% |
429,507
+216,957
| +102% | +$537K |
|
|
EVBN
3049
DELISTED
Evans Bancorp Inc
EVBN
| $1.3M | ﹤0.01% |
55,901
-1,555
| -3% | -$38.2K |
|
3050
Electromed
ELMD
$346M
| $1.3M | ﹤0.01% |
84,407
+61,130
| +263% | +$845K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.